These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 37474226

  • 1. The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study.
    Chen S, Kuhn M, Prettner K, Yu F, Yang T, Bärnighausen T, Bloom DE, Wang C.
    Lancet Glob Health; 2023 Aug; 11(8):e1183-e1193. PubMed ID: 37474226
    [Abstract] [Full Text] [Related]

  • 2. The global macroeconomic burden of Alzheimer's disease and other dementias: estimates and projections for 152 countries or territories.
    Chen S, Cao Z, Nandi A, Counts N, Jiao L, Prettner K, Kuhn M, Seligman B, Tortorice D, Vigo D, Wang C, Bloom DE.
    Lancet Glob Health; 2024 Sep; 12(9):e1534-e1543. PubMed ID: 39151988
    [Abstract] [Full Text] [Related]

  • 3. The global macroeconomic burden of road injuries: estimates and projections for 166 countries.
    Chen S, Kuhn M, Prettner K, Bloom DE.
    Lancet Planet Health; 2019 Sep; 3(9):e390-e398. PubMed ID: 31538624
    [Abstract] [Full Text] [Related]

  • 4. Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050.
    Chen S, Cao Z, Prettner K, Kuhn M, Yang J, Jiao L, Wang Z, Li W, Geldsetzer P, Bärnighausen T, Bloom DE, Wang C.
    JAMA Oncol; 2023 Apr 01; 9(4):465-472. PubMed ID: 36821107
    [Abstract] [Full Text] [Related]

  • 5. Global economic consequences of selected surgical diseases: a modelling study.
    Alkire BC, Shrime MG, Dare AJ, Vincent JR, Meara JG.
    Lancet Glob Health; 2015 Apr 27; 3 Suppl 2(Suppl 2):S21-7. PubMed ID: 25926317
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of population-based screening for chronic obstructive pulmonary disease in China: a simulation modeling study.
    Chen Q, Fan Y, Huang K, Li W, Geldsetzer P, Bärnighausen T, Yang T, Wang C, Chen S.
    Lancet Reg Health West Pac; 2024 May 27; 46():101065. PubMed ID: 38721063
    [Abstract] [Full Text] [Related]

  • 7. The macroeconomic burden of noncommunicable diseases and mental health conditions in South America.
    Ferranna M, Cadarette D, Chen S, Ghazi P, Ross F, Zucker L, Bloom DE.
    PLoS One; 2023 May 27; 18(10):e0293144. PubMed ID: 37862345
    [Abstract] [Full Text] [Related]

  • 8. The Impact of Alzheimer's Disease on the Chinese Economy.
    Keogh-Brown MR, Jensen HT, Arrighi HM, Smith RD.
    EBioMedicine; 2016 Feb 27; 4():184-90. PubMed ID: 26981556
    [Abstract] [Full Text] [Related]

  • 9. Socioeconomic differentials of trends in the prevalence and economic burden of chronic obstructive pulmonary disease in rural southwest China.
    Cai L, Wang XM, Liu L, Zhao Y, Golden AR.
    BMC Public Health; 2023 Jan 20; 23(1):141. PubMed ID: 36670366
    [Abstract] [Full Text] [Related]

  • 10. The care cascade of chronic obstructive pulmonary disease in China: a cross-sectional study of individual-level data at enrolment into the national 'Happy Breathing' Programme.
    Wang C, Qi W, Yang T, Jiao L, Chen Q, Huang K, Yu F, Geldsetzer P, Bärnighausen T, Chen S.
    EClinicalMedicine; 2024 Aug 20; 74():102597. PubMed ID: 39114273
    [Abstract] [Full Text] [Related]

  • 11. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study.
    Bommer C, Heesemann E, Sagalova V, Manne-Goehler J, Atun R, Bärnighausen T, Vollmer S.
    Lancet Diabetes Endocrinol; 2017 Jun 20; 5(6):423-430. PubMed ID: 28456416
    [Abstract] [Full Text] [Related]

  • 12. The macroeconomic burden of noncommunicable diseases associated with air pollution in China.
    Chen S, Bloom DE.
    PLoS One; 2019 Jun 20; 14(4):e0215663. PubMed ID: 30998763
    [Abstract] [Full Text] [Related]

  • 13. Modeling the Health and Economic Burden of Chronic Obstructive Pulmonary Disease in China From 2020 to 2039: A Simulation Study.
    Park JE, Zhang L, Ho YF, Liu G, Alfonso-Cristancho R, Ismaila AS, Zafari Z.
    Value Health Reg Issues; 2022 Nov 20; 32():8-16. PubMed ID: 35961283
    [Abstract] [Full Text] [Related]

  • 14. Labour productivity and economic impacts of carbon mitigation: a modelling study and benefit-cost analysis.
    Zhao M, Huang X, Kjellstrom T, Lee JKW, Otto M, Zhang X, Romanello M, Zhang D, Cai W.
    Lancet Planet Health; 2022 Dec 20; 6(12):e941-e948. PubMed ID: 36495888
    [Abstract] [Full Text] [Related]

  • 15. The Macroeconomic Impact of Increasing Investments in Malaria Control in 26 High Malaria Burden Countries: An Application of the Updated EPIC Model.
    Patouillard E, Han S, Lauer J, Barschkett M, Arcand JL.
    Int J Health Policy Manag; 2023 Dec 20; 12():7132. PubMed ID: 38618809
    [Abstract] [Full Text] [Related]

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 17. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis.
    Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I, NIHR RESPIRE Global Respiratory Health Unit.
    Lancet Respir Med; 2022 May 01; 10(5):447-458. PubMed ID: 35279265
    [Abstract] [Full Text] [Related]

  • 18. Macroeconomic costs of the unmet burden of surgical disease in Sierra Leone: a retrospective economic analysis.
    Grimes CE, Quaife M, Kamara TB, Lavy CBD, Leather AJM, Bolkan HA.
    BMJ Open; 2018 Mar 14; 8(3):e017824. PubMed ID: 29540407
    [Abstract] [Full Text] [Related]

  • 19. Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study.
    Vollset SE, Goren E, Yuan CW, Cao J, Smith AE, Hsiao T, Bisignano C, Azhar GS, Castro E, Chalek J, Dolgert AJ, Frank T, Fukutaki K, Hay SI, Lozano R, Mokdad AH, Nandakumar V, Pierce M, Pletcher M, Robalik T, Steuben KM, Wunrow HY, Zlavog BS, Murray CJL.
    Lancet; 2020 Oct 17; 396(10258):1285-1306. PubMed ID: 32679112
    [Abstract] [Full Text] [Related]

  • 20. How feasible is it to mobilize $31 billion a year for pandemic preparedness and response? An economic growth modelling analysis.
    Shahid M, Schäferhoff M, Brown G, Yamey G.
    Global Health; 2024 Jul 19; 20(1):54. PubMed ID: 39030585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.